Table 2.
Clinical features of patients with pediatric- and adult-onset morphea; values expressed as mean (SEM) unless otherwise specified
| Pediatric-onset | Adult-onset | P value | |
|---|---|---|---|
| MRSS, number scored | 68 | 232 | |
| MRSS score | 5.2 (0.6) | 6.3 (0.4) | 0.2 |
| LoSCAT, number scored | 55 | 186 | |
| mLoSSI | 4.2 (1.3) | 15.6 (1.6) | 0.0002 |
| LoSDI | 16.1 (2.0) | 17.3 (1.2) | 0.62 |
| PGA-A | 11.1 (2.5) | 34.6 (2.3) | <0.0001 |
| PGA-D | 37.7 (3.3) | 27.2 (1.5) | 0.002 |
| Active disease, n (%) | 21 (38) | 144 (77) | <0.0001 |
| Functional impairment, n (%) | 21 (30) | 46 (20) | 0.07 |
| Deep involvement, n (%) | 49 (70) | 106 (45) | 0.0002 |